CTEV
Get informed when a big investor buys or sells
+ FollowOvervalued by 228.2% based on the discounted cash flow analysis.
| Market cap | $635.37 Million |
|---|---|
| Enterprise Value | $5.24 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-17.3 |
| Beta | 0.79 |
| Outstanding Shares | 16,964,960 |
| P/E Ratio | -2.19 |
|---|---|
| PEG | 40.2 |
| Price to Sales | 0.65 |
| Price to Book Ratio | -2.21 |
| Enterprise Value to Revenue | 5.27 |
| Enterprise Value to EBIT | 164.56 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.88 |
| Debt to Equity | -15.69 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5436▲ 25.54% |
|---|---|
| Total Calls | 67,700▼ 34.53% |
| Total Puts | 36,800▲ 23.49% |
Holdings and activity of institutional investors.
| Ownership % | 86.12%▲ 0.38% |
|---|---|
| Total Invested | $231.48M▼ 61.58% |
| Investors Holding | 99▼ 11.00% |
No data
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-...